Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective single-center study of contezolid tablets in Gram-positive pulmonary infection
ChiCTR2400093212Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of contezolid in bacterial pneumonia, sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Efficacy (clinical cure rate of Gram-positive pulmonary infection). Planned start Nov 2024; status: not yet recruiting.
02
Drugs
contezolid
03
Conditions
bacterial pneumonia
Beyond the preview
Go deeper on ChiCTR2400093212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093212.